Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Fibroblast growth factor 21 (FGF21) ELISA Kit-Sandwich

Name: Canine Fibroblast growth factor 21 (FGF21) ELISA Kit-Sandwich
SKU: EK10F879
Rating: 5 (1 reviews)

Cat. No.EK10F879

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine FGF21 ELISA Kit-Sandwich is designed for the quantitative determination of Canine FGF21 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine FGF21.

Target Species Canine

Species Reactivity Canine

Detection Range 62.5-4000 pg/mL

Sensitivity 12.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Fibroblast growth factor 21 is encoded by the FGF21 gene in dogs. It lowers blood glucose levels, improves insulin sensitivity, and induces weight loss in several animal models.

Target/Biomarker Canine FGF21

Target Synonym fibroblast growth factor 21

Gene ID 484395

UniProt ID E2RRP8

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Corbee, R. J. et al. Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients. Front Vet Sci. 2022, 9: 1086987.